- Home
- MDGL vs XP Comparison
MDGL vs XP Comparison
Compare MDGL & XP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- XP
- Stock Information
- Founded
- MDGL 2011
- XP 2001
- Country
- MDGL United States
- XP Cayman Islands
- Employees
- MDGL N/A
- XP N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- XP Investment Bankers/Brokers/Service
- Sector
- MDGL Health Care
- XP Finance
- Exchange
- MDGL Nasdaq
- XP Nasdaq
- Market Cap
- MDGL 9.6B
- XP 8.6B
- IPO Year
- MDGL N/A
- XP 2019
- Fundamental
- Price
- MDGL $423.00
- XP $18.25
- Analyst Decision
- MDGL Strong Buy
- XP Strong Buy
- Analyst Count
- MDGL 12
- XP 5
- Target Price
- MDGL $521.09
- XP $22.40
- AVG Volume (30 Days)
- MDGL 277.8K
- XP 6.8M
- Earning Date
- MDGL 11-04-2025
- XP 11-18-2025
- Dividend Yield
- MDGL N/A
- XP 7.58%
- EPS Growth
- MDGL N/A
- XP 18.07
- EPS
- MDGL N/A
- XP 1.67
- Revenue
- MDGL $515,547,000.00
- XP $3,085,301,717.00
- Revenue This Year
- MDGL $394.38
- XP $16.93
- Revenue Next Year
- MDGL $64.73
- XP $11.96
- P/E Ratio
- MDGL N/A
- XP $10.89
- Revenue Growth
- MDGL 3421.98
- XP 6.65
- 52 Week Low
- MDGL $213.71
- XP $10.82
- 52 Week High
- MDGL $463.63
- XP $20.64
- Technical
- Relative Strength Index (RSI)
- MDGL 46.87
- XP 60.25
- Support Level
- MDGL $393.61
- XP $17.47
- Resistance Level
- MDGL $434.48
- XP $18.55
- Average True Range (ATR)
- MDGL 16.23
- XP 0.48
- MACD
- MDGL -2.55
- XP 0.23
- Stochastic Oscillator
- MDGL 51.20
- XP 89.93
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About XP XP Inc.
XP Inc is a Cayman Island-based technology-driven financial services platform. It is a provider of low-fee financial products and services in Brazil. The company evaluates its business through a single segment such as monitoring operations, making decisions on fund allocation, and evaluating the performance. It generates revenue through the Brokerage commission.